Top Buy
| Security | Buy | Sell | Buy (1M) ▼ | Sell (1M) | Price | Target price | Potential |
|---|---|---|---|---|---|---|---|
| Biocryst Pharmaceuticals | 10 | 0 | 3 | 0 | €4.90 | €11.05 | 125.683% |
| BioMarin Pharmaceutical Inc. | 20 | 0 | 3 | 0 | €76.80 | €102.62 | 33.618% |
| LivaNova plc | 9 | 0 | 3 | 0 | €59.00 | €66.59 | 12.869% |
| Rhythm Pharmaceuticals | 15 | 0 | 3 | 0 | €36.60 | €45.98 | 25.628% |
| MacroGenics Inc. | 11 | 0 | 3 | 0 | €14.93 | €20.00 | 33.958% |
| Stoke Therapeutics Inc | 15 | 1 | 3 | 0 | €11.20 | €21.00 | 87.532% |
| Icon plc | 18 | 0 | 3 | 0 | €292.50 | €319.67 | 9.289% |
| X4 Pharmaceuticals, Inc. | 6 | 0 | 3 | 0 | €1.01 | €2.78 | 175.114% |
| Ultragenyx Pharmaceutical Inc. | 17 | 1 | 3 | 0 | €40.00 | €84.74 | 111.860% |
| EyePoint Pharmaceuticals Inc. | 16 | 1 | 2 | 1 | €11.03 | €27.79 | 151.913% |
| Taro Pharmaceutical Industries Ltd | 8 | 0 | 2 | 0 | €39.20 | - | - |
| Masimo Corp. | 7 | 1 | 2 | 0 | €126.40 | €147.62 | 16.785% |
| Cytokinetics Inc. | 24 | 1 | 2 | 0 | €60.50 | €84.57 | 39.788% |
| Merck & Co. Inc. | 28 | 1 | 2 | 0 | €121.40 | €124.93 | 2.907% |
| Insmed Inc. | 13 | 1 | 2 | 0 | €24.00 | €44.01 | 83.361% |
| Abbott Laboratories | 16 | 0 | 2 | 0 | €98.64 | €116.81 | 18.418% |
| Blueprint Medicines Corp | 2 | 0 | 2 | 0 | €101.00 | - | - |
| Actinium Pharmaceuticals Inc. | 4 | 0 | 2 | 0 | €8.17 | €10.00 | 22.399% |
| Adverum Biotechnologies Inc. | 6 | 1 | 2 | 0 | €1.38 | €4.66 | 237.768% |
| Idexx Laboratories Inc. | 11 | 0 | 2 | 0 | €450.00 | €552.72 | 22.826% |
| Ensign Group Inc. | 9 | 0 | 2 | 0 | €109.00 | €116.99 | 7.332% |
| Evolus Inc | 7 | 0 | 2 | 0 | €12.20 | €20.26 | 66.028% |
| Laboratory Corp. Of America (labcorp) | 11 | 0 | 2 | 0 | €188.00 | €237.94 | 26.564% |
| Dexcom Inc. | 18 | 0 | 2 | 0 | €120.92 | €136.82 | 13.151% |
| Fate Therapeutics Inc. | 5 | 2 | 2 | 0 | €3.60 | €8.27 | 129.489% |